Christopher Y Park

Affiliations: 
2004-2009 Pathology New York University School of Medicine, New York, NY, United States 
Area:
Hematopathology
Website:
https://nyulangone.org/doctors/1386786317/christopher-y-park
Google:
"Christopher Y. Park, MD, PhD"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Christian Schindler grad student 2001 Columbia (Microtree)
 (The role of Stat2 in interferon biology.)
Irving L. Weissman post-doc 2004-2009 Stanford Medical School (FlyTree)

Children

Sign in to add trainee
Mona Khalaj grad student 2011-2017 Memorial Sloan Kettering Cancer Center (Stem Cell Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pang WW, Czechowicz A, Logan AC, et al. (2019) Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood
Tavakkoli M, Chung SS, Park CY. (2018) Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes? Expert Opinion On Therapeutic Targets
Cimmino L, Dolgalev I, Wang Y, et al. (2017) Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell
Khalaj M, Woolthuis CM, Hu W, et al. (2017) miR-99 regulates normal and malignant hematopoietic stem cell self-renewal. The Journal of Experimental Medicine
Khalaj M, Park CY. (2017) snoRNAs contribute to myeloid leukaemogenesis. Nature Cell Biology. 19: 758-760
Chung SS, Eng WS, Hu W, et al. (2017) CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Science Translational Medicine. 9
Elias HK, Khalaj M, Park CY. (2016) Divergent roles of in normal and malignant stem cells. Translational Cancer Research. 5: S328-S331
Ye H, Adane B, Khan N, et al. (2016) Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche. Cell Stem Cell
Park CY. (2016) Context matters in MLL-AF9-driven leukemias. Blood. 127: 2268-9
Woolthuis CM, Park CY. (2016) Hematopoietic stem/progenitor cell commitment to the megakaryocyte lineage. Blood
See more...